Although neither treatment restored the colitis levels observed in IL-23-sufficient RAG-deficient recipients upon T cell transfer (typical colitis score of 8–9), these results suggest that in the absence of IL-23 there is a shift toward IL-10- and TGF-β-mediated immune suppression that masks potential inflammatory pathways. The gene discussed is IL23A; the disease is colitis.